Generation of cytotoxic effector cells against human melanoma |
| |
Authors: | Stanley P. L. Leong Yuan-Ming Zhou Michael E. Granberry Ti-Fen Wang Thomas M. Grogan Catherine Spier Ruby White Abhay Mehta Augustine Y. Lin |
| |
Affiliation: | (1) Department of Surgery, University of Arizona, 85724 Tucson, AZ, USA;(2) Arizona Cancer Center, University of Arizona, 85724 Tucson, AZ, USA;(3) Department of Pathology, University of Arizona, 85724 Tucson, AZ, USA;(4) Transfusion Medicine, College of Medicine, University of Arizona, 85724 Tucson, AZ, USA;(5) T Cell Sciences Inc., 02139 Cambridge, MA, USA;(6) Department of Surgery, University of California, San Francisco/Mount Zion Cancer Center, P.O. Box 7921, 94120 San Francisco, CA, USA |
| |
Abstract: | Metastatic or tumor-draining lymph nodes from six of nine melanoma patients undergoing lymph node dissection for metastatic melanoma generated cytotoxic T cells against autologous melanoma when these lymph node cells were treated by in vitro sensitization and recombinant interleukin-2 (IL-2). During the initial lymphocyte culture (2–6 weeks), cross-reactivity with autologous tumor cells, K562 and Daudi cells was usually noted. Cold-target inhibition assay with K562 and Daudi showed K562/Daudi-associated antigens on melanoma cells. During the later phase of lymphocyte culture with repeated in vitro sensitization (over 6–10 weeks), cytotoxicity was noted against autologous and allogeneic melanoma cells but not against K562, Daudi cells or autologous fibroblasts. Repeated in vitro sensitization resulted in the selection of specific cytotoxic lymphocytes against melanoma. Cold-target inhibition assay with autologous and allogeneic melanoma cells revealed shared and individual antigens. Using blocking monoclonal antibodies, MHC-restricted killing was noted in the autologous system. Further, both the autologous and allogeneic systems could be mediated through adhesion molecules such as ICAM-1 and LFA-3 on melanoma cells and LFA-1 on T cells. This study suggests that a constellation of cytotoxic effector cells and melanoma-associated antigens may be pivotal in tumor killing. Thus, future adoptive immunotherapy should modulate and enhance this complex interaction.This work was supported by an Elsa, U. Pardee Foundation grant, the Arizona Chronic Disease Research Commission grant and partly by grant CA23074 from the National Institutes of Health, Bethesda, MD, 20892 |
| |
Keywords: | Generation Lymphocytes Melanoma |
本文献已被 SpringerLink 等数据库收录! |
|